Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

New gene associated with cardiovascular disease identified

Nov. 5, 2007

In vivo antinociceptive effects reported for novel alpha2-adrenoceptor agonist

Nov. 5, 2007

DTS-201 safe in first-in-man study

Nov. 5, 2007

Studies detail efficacy of sugammadex in reversing neuromuscular blockade

Nov. 5, 2007

Novel candidate gene for Parkinson's disease identified

Nov. 5, 2007

Favorable results seen in phase I study of XMT-1001

Nov. 2, 2007

TST-10088 well tolerated in ongoing phase I study

Nov. 2, 2007

The Hsp90 inhibitor NVP-AUY-922 profiled at the AACR-NCI-EORTC meeting

Nov. 2, 2007

SNAP25 may be a common susceptibility gene for ADHD and early-onset bipolar affective disorder

Nov. 2, 2007

CAM-24 shows antipsychotic activity in vivo with low potential for motor side effects

Nov. 2, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...